greeksoup/ stock research

Universal Health Services (UHS) FY2024 results: revenue $15.8 billion, up 10.8% on the year

Universal Health Services Inc. (UHS) reported revenue of $15.8 billion for fiscal 2024, the year ended 31 December 2024, up 10.8% on the year before. Net income was $1.1 billion, up 59.1%, and diluted earnings per share $16.82. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2025.

Revenue
$15.8 billion
+10.8% on the year
FY2017FY2024
Operating margin
10.6%
8.2% a year earlier
FY2017FY2024
Net income
$1.1 billion
+59.1% on the year
FY2017FY2024
Diluted EPS
$16.82
+64.4% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue15,82814,28213,399+10.8%
Operating income1,6821,1751,004+43.1%
Operating margin10.6%8.2%7.5%
Interest expense186207127-10.0%
Pre-tax income1,498940866+59.3%
Income tax335221209+51.4%
Effective tax rate22.4%23.5%24.2%
Net income1,142718676+59.1%
Net margin7.2%5.0%5.0%
Diluted EPS$16.82$10.23$9.14+64.4%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow2,0671,268996+63.0%
Capital expenditure944743734+27.0%
Free cash flow1,123525262+114.1%
Free cash flow margin7.1%3.7%2.0%
Cash from investing-911-763-647
Cash from financing-1,145-494-318
Depreciation and amortisation585568582+3.0%
Share-based compensation99.387.785.4+13.3%
Buybacks671547833+22.5%
Dividends paid53.355.558.4-3.8%
Dividend per share$0.80$0.80$0.800.0%
Diluted shares, weighted68m70m74m-3.2%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity6,6666,1495,921+8.4%
Non-controlling interest83.347.744.8+74.6%
Redeemable equity13.35.24.7+156.1%
Debt4,5054,9124,808-8.3%
Operating lease liabilities376383396-1.7%
Finance lease liabilities87.269.672.5+25.3%
Other liabilities2,7392,4012,248+14.1%
Total liabilities and equity14,47013,96813,494+3.6%
Fixed assets6,5726,1255,918+7.3%
Goodwill3,9333,9323,909+0.0%
Intangible assets76.377.078.1-1.0%
Cash and equivalents126119103+5.5%
Receivables2,1782,2382,018-2.7%
Other assets1,5851,4761,468+7.4%
Total assets14,47013,96813,494+3.6%

10-K for the year ended 31 December 2024, filed 26 February 2025: the filing.